A hypoglossal nerve stimulator implant is a device surgically placed inside the body to treat obstructive sleep apnea.

This outpatient surgery involves an implant that stimulates the hypoglossal ... is very likely to pay for all or most of the ...

DALLAS — For more information visit enttx.com/inspire.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $215.54, a high ...

Approximately 30 million U.S. adults are believed to have sleep apnea, but only 6 million have been officially diagnosed.

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

Inspire Medical Systems Inc. announced that Dr. Paul T. Hoff has joined the company as vice president and senior medical ...

The company continues to focus on innovation and patient outcomes in the sleep apnea treatment ... rates for the Inspire 5 therapy, UBS believes the ease of the implant procedure could encourage ...

Over the past few years, he has performed more than 100 procedures to implant a device called Inspire into people with sleep apnea who have not had success with other treatments, such as CPAP ...

(AP) — Inspire Medical Systems Inc. (INSP ... The maker of devices for treating obstructive sleep apnea posted revenue of $201.3 million in the period, which also beat Street forecasts.

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

Inspire Medical Systems, Inc. ( NYSE: INSP) Q1 2025 Results Conference Call May 5, 2025 5:00 PM ET Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer ...